Efficient translation initiation and optimal stability of most eukaryotic messenger RNAs depends on the formation of a closed-loop structure and the resulting synergistic interplay between the 59 m 7 G cap and the 39 poly(A) tail 1,2 . Evidence of eIF4G and Pab1 interaction supports the notion of a closed-loop mRNP 3 , but the mechanistic events that lead to its formation and maintenance are still unknown. Here we use toeprinting and polysome profiling assays to delineate ribosome positioning at initiator AUG codons and ribosome-mRNA association, respectively, and find that two distinct stable (resistant to cap analogue) closed-loop structures are formed during initiation in yeast cell-free extracts. The integrity of both forms requires the mRNA cap and poly(A) tail, as well as eIF4E, eIF4G, Pab1 and eIF3, and is dependent on the length of both the mRNA and the poly(A) tail. Formation of the first structure requires the 48S ribosomal complex, whereas the second requires an 80S ribosome and the termination factors eRF3/ Sup35 and eRF1/Sup45. The involvement of the termination factors is independent of a termination event.
1
Efficient translation initiation and optimal stability of most eukaryotic messenger RNAs depends on the formation of a closed-loop structure and the resulting synergistic interplay between the 59 m 7 G cap and the 39 poly(A) tail 1, 2 . Evidence of eIF4G and Pab1 interaction supports the notion of a closed-loop mRNP 3 , but the mechanistic events that lead to its formation and maintenance are still unknown. Here we use toeprinting and polysome profiling assays to delineate ribosome positioning at initiator AUG codons and ribosome-mRNA association, respectively, and find that two distinct stable (resistant to cap analogue) closed-loop structures are formed during initiation in yeast cell-free extracts. The integrity of both forms requires the mRNA cap and poly(A) tail, as well as eIF4E, eIF4G, Pab1 and eIF3, and is dependent on the length of both the mRNA and the poly(A) tail. Formation of the first structure requires the 48S ribosomal complex, whereas the second requires an 80S ribosome and the termination factors eRF3/ Sup35 and eRF1/Sup45. The involvement of the termination factors is independent of a termination event.
In vitro translation reactions used synthetic mRNAs derived from yeast transcripts, extracts that recapitulate synergy between the cap and the poly(A) tail ( Supplementary Fig. 1a ), competitive inhibition of translation initiation by m 7 GpppG (cap analogue), and analyses of ribosome positioning or mRNA association by toeprinting and sucrose-gradient sedimentation. Addition of the elongation inhibitor cycloheximide to translation reactions programmed by the 2,135-nucleotide (nt) AAA and UAA mRNAs containing long or short open reading frames, respectively (Fig. 1a) , allowed the detection of cycloheximide-dependent initiator AUG toeprints that reflect 80S ribosomes protecting 16-18 nt 39 of the AUG codon [4] [5] [6] (Fig. 1b , left and top right panels, lanes 1 and 3). These toeprints were dependent on initiation codon recognition, the presence of yeast extract, and concurrent mRNA translation ( Supplementary Fig. 1b, c) . Supporting the latter conclusion, toeprints were almost completely eliminated by 2.7 mM cap analogue, a concentration that distinguished genuine toeprints from background bands (Fig. 1b, left and top right panels, lanes 2 and 4). Lower concentrations of cap analogue also inhibited AUG toeprint accumulation, with 70% and 96% sensitivity obtained at 0.05 mM and 0.5 mM, respectively (Fig. 1b, bottom right panel) . A shorter mRNA (miniUAA1, 488 nt; Fig. 1a ) also yielded the AUG toeprint (Fig. 1c , left panel, lane 1), but this band was resistant to 2.7 mM cap analogue (lane 2) and manifested sensitivity only at higher concentrations (Fig. 1c, right  panel) . Thus, in wild-type extracts, the short capped (see Supplementary Fig. 1d ) and polyadenylated miniUAA1 mRNA is about 160-fold more resistant to cap analogue than the longer AAA mRNA. The miniADE2 (485 nt) and ADE2 (2,070 nt) mRNAs, whose respective sizes (but not sequences) are comparable to those of the miniUAA1 and AAA transcripts, also show the same results (Supplementary Fig. 2a ). In agreement with the apparent mRNA size dependence of cap analogue resistance in vitro, mRNAs with intermediate sizes (from 488 to 2,135 nt), but with the same stability ( Supplementary Fig. 2b ), showed intermediate phenotypes, with about 40% sensitivity to 2.7 mM cap analogue obtained with an 882-nt mRNA, 60% sensitivity with a 1,105-nt mRNA, and nearmaximal sensitivity with a 1,336-nt mRNA (Fig. 1d) .
To rule out cap-independent translation as the basis for cap analogue resistance, we translated and toeprinted a polyadenylated miniUAA1 mRNA with no 59 cap. This mRNA, which is stable during translation ( Supplementary Fig. 2c ), initiates inefficiently in wildtype extracts (Fig. 2a, lane 1) , strongly suggesting that translation of our reporter mRNAs is cap-dependent. As reported previously 7, 8 , the addition of cap analogue stimulates the translation of uncapped mRNA (Fig. 2a, lane 2) , possibly because it titrates other inhibitors. Taken together, these data suggest that interactions between the eIF4F cap-binding complex and the 59 m 7 G cap of the mini-mRNAs are much stronger than those occurring with the long mRNAs.
Short mRNAs may be preferentially resistant to cap analogue because they form a more stable closed-loop mRNP than long mRNAs, possibly by promoting increased affinity of mRNP factors for each other or for mRNA structures such as the 59 cap 3, [9] [10] [11] . To test the relationship of the closed-loop state to m 7 GpppG resistance, we analysed the toeprinting of capped, poly(A) 2 miniUAA1 mRNA. This transcript showed strong sensitivity to cap analogue (Fig. 2b , lane 2). Further analyses of miniUAA1 mRNAs having different poly(A) tail lengths (but identical stabilities; Supplementary Fig.  2d ) showed that miniUAA1 mRNA with a poly(A) tail of 14 or 18 adenosines (Fig. 2c, lanes 1-4) displayed a phenotype similar to poly(A)-deficient mRNA (more than 95% sensitivity to 2.7 mM cap analogue). Increasing the poly(A) tail length to 22, 25 or 33 residues yielded an intermediate phenotype (about 80% sensitivity to cap analogue; Fig. 2c, lanes 5-10) , whereas a miniUAA1 mRNA with 57 adenosines showed no sensitivity to 2.7 mM cap analogue (Fig. 2c, lanes 11 and 12) . These results correlate cap analogue resistance with poly(A) length, a result consistent with the formation of a closed loop. Because Pab1-poly(A) association requires a minimum of 12 adenosines, and multiple Pab1 molecules can bind the same poly(A) tract in a 27-nt repeating unit [12] [13] [14] , it seems that at least two Pab1 molecules are required for a stable closed-loop structure. In concord with this conclusion, previous studies showed that an A 15 tail did not suffice to stimulate translation in Drosophila 15 and mammalian 16 extracts, but that longer poly(A) tails promoted strong translational enhancement.
Toeprinting of miniUAA1 mRNA after translation in Pab1-deficient (pab1Dpbp1D) extracts reinforced the notion of a critical role for Pab1 in cap analogue resistance. Translation initiation in these extracts was highly sensitive to cap analogue (Fig. 3a , lanes 3 and 4; compare with extracts from wild-type (lanes 1 and 2) or pbp1D (a pab1D suppressor) cells (lanes 5 and 6)), and the apparent 80-fold increase in sensitivity to cap analogue (Fig. 1c, right panel, and Supplementary Fig. 5b, top panel) was directly attributable to the absence of Pab1 because supplementation with 15 pmol of recombinant Pab1, but not the same amount of BSA, restored cap analogue resistance to wild-type levels ( Supplementary Fig. 5a ). Although Pab1 is essential for cap analogue resistance, its level must be well balanced because excess Pab1-that is, the addition of 15 pmol of Pab1 to wild-type extracts (lanes 3 and 4) or 38 pmol of Pab1 to pab1Dpbp1D extracts (data not shown)-reduces the extent of cap analogue resistance.
To further evaluate the relationship between cap analogue resistance and the formation of a closed loop, we determined whether the same regions of Pab1 were required for both phenomena. Extracts derived from pab1-134 cells, in which Pab1 has a wild-type affinity for eIF4G1 but a decreased affinity for eIF4G2 (ref. 17) (yeast has two eIF4G isoforms encoded by the functionally redundant TIF4631 and TIF4632 genes, respectively 18 ), had a wild-type phenotype (Fig. 3a , lanes 7 and 8). However, toeprinting analyses in pab1-184 extracts, in which Pab1 does not bind to eIF4G1 or eIF4G2 (ref. 17) , revealed a strong sensitivity to cap analogue (Fig. 3a, lanes 9 and 10) . Similarly, extracts of pab1-DRRM1 cells, in which Pab1 has lost the ability to interact with the poly(A) tail, and probably with either isoform of eIF4G as well 19 , also show strong sensitivity to cap analogue ( 13 and 14) shows that this mutation also confers sensitivity to cap analogue, although 2.5-fold less sensitivity than that observed in pab1Dpbp1D extracts ( Supplementary Fig. 5b, d ). In addition, the pattern of toeprint inhibition with the pab1-DC-term extract has a different appearance from that seen with other pab1 mutants (Supplementary Fig. 5b, d ), suggesting that the Pab1 carboxy-terminal domain may be involved in a step distinct from that involving the other domains. All of the pab1 mutant extracts show full sensitivity to cap analogue when programmed with poly(A) 2 miniUAA1 mRNA ( Supplementary Fig. 2f ). Recombinant Pab1 could not complement the phenotypes of these extracts when supplemented with polyadenylated miniUAA1 mRNA, further suggesting dominant-negative effects of the mutated proteins (data not shown). The differences in sensitivity of the different pab1 extracts to cap analogue are consistent with the loss of interactions characteristic of the involvement of specific Pab1 domains 21 in closed-loop mRNP formation and stabilization. Accordingly, we analysed miniUAA1 mRNA toeprints in extracts from strains harbouring mutations in genes encoding different Pab1-interacting proteins. Extracts of eIF4G1-DN300 cells 17 , in which there is no eIF4G2 and Pab1-eIF4G1 interaction is disrupted, show strong sensitivity to cap analogue and correlate well with the cap analogue-sensitivity phenotype of pab1-184 extracts (Fig. 3b and Supplementary Fig. 5c ). Similarly, extracts harbouring mutated eRF3 (sup35-R419G) 22 or eRF1 (sup45-2)
23 termination factors show both sensitivity to cap analogue (but not to GTP; Supplementary Fig. 2e ) and toeprint patterns that are strikingly similar to those obtained with the pab1-DC-term extract ( Fig. 3c and Supplementary Fig. 5d ), with the exception that they also yield two extra bands 59 of the AUG toeprint that are suggestive of initiation anomalies (see Supplementary Data and Supplementary  Fig. 3a) . Control reactions demonstrated that the termination mutant extracts were fully sensitive to cap analogue when programmed with poly(A) 2 miniUAA1 mRNA ( Supplementary Fig.  2g) and that the addition of extra Mg 21 to the different translation reactions (to compensate for a possible titration by cap analogue) had no effect on their toeprint phenotypes ( Supplementary Fig. 2h ). These results, and the observation that toeprinting of miniUAA1 mRNA after translation in extracts defective in eIF3 and eIF4E also exhibited more sensitivity to cap analogue than did wild-type extracts ( Supplementary Fig. 4 ), imply that cap analogue resistance results from formation of a stable closed-loop structure.
Further insights into the formation of a closed loop followed from experiments using extracts supplemented with mutant transcripts or different competitive inhibitors, or independent analytical methods. First, we evaluated whether the role of eIF4G-Pab1-eRF3 interactions in the formation of a closed loop (and, possibly, ribosome recycling 24 ) was also dependent on translation termination 24 . We prepared a mini-mRNA with no stop codon (nonstopminiUAA1) and analysed its response to cap analogue in extracts derived from wildtype or termination-defective cells. Translation of nonstopminiUAA1 in wild-type extracts showed strong cap analogue resistance (Fig. 3d,  lanes 1 and 2) , suggesting that conventional termination steps are not required for a stable closed-loop mRNP. In contrast, sup35-R419G and sup45-2 extracts programmed with nonstopminiUAA1 RNA showed strong sensitivity to cap analogue (Fig. 3d, lanes 3-6) , indicating that, although termination itself is not required, de novo formation of a stable closed-loop structure in yeast is dependent on the principal termination factors. Second, because there was no requirement for termination, we considered the possibility that the formation of a closed loop precedes the first round of mRNA translation; we therefore analysed the toeprinting of miniUAA1 mRNA after 2-min time courses of translation in wild-type or Pab1-mutant extracts. In wild-type extracts, cap analogue-resistant AUG toeprints were obtained within 30 s of incubation with miniUAA1 mRNA. Similarly, in pab1-184 and pab1-DRRM1 extracts, sensitivity to cap analogue was observed at the same time point (Fig. 3e, f) . Third, to monitor mRNA-ribosome association by an independent method, we used sucrose-gradient fractionation to analyse the translation of miniUAA1 mRNA. Figure 3g shows that, in the absence of cap e, f, Cap analogue resistance or sensitivity of miniUAA1 mRNA appears at the onset of translation in wild-type (e) or Pab1-defective (f) extracts. g, Sucrose-gradient fractionation of miniUAA1 mRNA translated in wildtype and mutant extracts in the absence (left) and presence (right) of cap analogue, and in the presence of cycloheximide. In g the values above the horizontal lines depict fraction numbers and those below the lines denote the respective percentages of mRNA associated with polysomal and nonpolysomal fractions.
analogue, 60-70% of miniUAA1 mRNA is associated with the polyribosomal fractions, whereas, in the presence of cap analogue, most of the miniUAA1 mRNA in the pab1-DRRM1, sup35-R419G and sup45-2 extracts associated with the non-polysomal fractions. In contrast, the mRNA translated in the wild-type extract showed the same distribution as in the absence of the drug. Taken together, these data provide additional evidence that translation of capped and polyadenylated miniUAA1 mRNA is resistant to cap analogue in wild-type extracts. The foregoing observations are consistent with the notion that interactions between the mRNP 59 and 39 ends are established early in the translation process (Fig. 3d-f) . We therefore sought to identify the step of translation initiation associated with the formation of a closed loop. The toeprinting assays described above used cycloheximide to stabilize the 80S ribosome on the initiator AUG 4 and thus monitored a late step in initiation. To determine whether closed-loop mRNP formation occurred earlier, we analysed mRNA toeprints in extracts supplemented with the non-hydrolysable GTP analogue GMP-PNP 4 , a drug that blocks the conversion of the 48S complex to an 80S ribosome in vitro. In both wild-type and pbp1D extracts, translation of miniUAA1 mRNA in the presence of GMP-PNP gave the same results as those observed with cycloheximide, namely full resistance to 2.7 mM cap analogue (Fig. 4a, lanes 1, 2 and 5, 6 ). This result implies that steps essential to establishing the closed-loop phenotype occur before or during formation of the 48S complex.
As observed with cycloheximide toeprinting, sensitivity of miniUAA1 mRNA in the presence of GMP-PNP was dependent on a poly(A) tail (data not shown) and the availability of functional Pab1 and eIF4G (Fig. 4a, lanes 3, 4, 7-16, and Fig. 4b, lanes 5-8) . However, alterations in termination factor activity yielded different toeprint phenotypes. Extracts of termination factor mutants supplemented with GMP-PNP either at the beginning of the reaction (data not shown) or after 4 min of translation were fully resistant to cap analogue and lacked the upstream toeprints detected with cycloheximide (Fig. 4c) . In agreement with these results, sucrose-gradient analyses of mRNA-ribosome association in extracts supplemented with GMP-PNP at the onset of the reaction showed no differences between the wild type and the termination mutant extracts in the presence or absence of cap analogue, whereas the pab1-DRRM1 extract had a phenotype characteristic of inhibition of translation initiation by cap analogue (Supplementary Fig. 5e ). Thus, although eRF1 and eRF3 do not seem to affect the rate of translation initiation (Supplementary Fig. 3d ) or the formation of the closed-loop mRNP that includes only the 48S complex, they are required on formation of the 80S ribosome to generate a second state of the closed-loop structure.
The 59 cap and 39 poly(A) tail act synergistically to promote the stability and translatability of an mRNP 21 . Here we show that these mRNA appendages communicate as the first round of translation begins, establishing interactions involving at least two molecules of poly(A)-associated Pab1, the initiation factors eIF4G, eIF4E and eIF3, and the termination factors eRF1 and eRF3. Two forms of the stable closed-loop structure can be distinguished during initiation on short, but not long, mRNAs in vitro. The first requires the preinitiation 48S complex but not eRF1 and eRF3, whereas the second is formed after 60S joining and requires the two eRFs as well as all the other components of the first structure. The restriction of the efficient formation of a closed loop in vitro to short mRNAs suggests that other factors facilitating this process may be absent or inactive in our cell-free system.
METHODS SUMMARY
Synthetic mRNAs of different sizes or sequences were translated in cell-free extracts derived from wild-type yeast cells or from mutant strains lacking the activity of specific translation factors. The elongation inhibitor cycloheximide or the non-hydrolysable GTP analogue GMP-PNP was used to trap 80S or 40S ribosomes at initiator AUG codons, and primer extension inhibition (toeprinting) assays were used to delineate the specific positions of those ribosomes on the different mRNAs. Polysome profiling assays, employing sucrose-gradient fractionation of translation reactions and subsequent northern blotting of gradient fractions, were used to assess ribosome-mRNA association. The cap analogue m 7 GpppG was used in all experiments as a competitive inhibitor of translation initiation.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 
METHODS
Synthetic mRNAs. Synthetic, capped poly(A)-containing miniUAA1, UAA and AAA mRNAs were transcribed in vitro from chimaeric genes cloned in a pSP65A vector that included about 65 dT residues for transcription of a poly(A) tail 5 . mRNAs of intermediate lengths originated from truncated DNA constructs derived from pSP65A-CAN1/LUC 5 by deletion of the LUC open reading frame from PstI restriction sites (created by site-directed mutagenesis; Stratagene). mRNAs differing in poly(A) tail length were synthesized from miniUAA1 DNA cloned in pSP65A vectors containing the corresponding lengths of dT residues 16 . The construct used for synthesis of long ADE2 mRNA was generated in a one-step PCR amplification, using EcoRI-site-containing oligonucleotide no. 165 (which also contains mutations of two upstream AUGs) (59-CGGAA-TTCATTATAGAGCATTTCATATATAAATTGGTGCGTAAAATCGTTGGAT-CTCTC-39) and BamHI site-containing oligonucleotide no. 164 (59-GAGGAT-CCAAATTCTTAAAAAAGGACACCTGTAAGCGTTG-39) and cloned into the EcoRI and BamHI restriction sites of the pSP65A vector. The miniADE2 DNA construct was generated by deletion of the 1,575-nt fragment from a PstI restriction site 260-265 nt downstream of the start of the construct and a PstI site immediately 59 to the normal stop codon (both sites were created by site-directed mutagenesis). All plasmid constructions were confirmed by DNA sequencing. Capped and polyadenylated RNAs were synthesized with the SP6 mMessage mMachine kit (Ambion), in accordance with the manufacturer's protocol, from HindIII-linearized plasmids for poly(A)-containing mRNA or from ClaI linearized plasmids for mRNA lacking the poly(A) tail. At least 80% of in vitro transcribed mRNAs were capped, as determined by immunoprecipitation with anti-2,2,7-trimethylguanosine agarose conjugate (Calbiochem). Uncapped mRNA was synthesized with the MEGAscript kit (Ambion). RNA yields were quantified by spectrophotometry and their integrities were assessed by agarosegel electrophoresis. Extracts and translation reactions. Saccharomyces cerevisiae strains [25] [26] [27] [28] [29] (Supplementary Table 1 ) were used to make extracts for in vitro translation by techniques described previously 6 . Wild-type strains from different genetic backgrounds gave similar results. Translation and toeprinting assays were essentially the same as those described previously 5 . Unless indicated otherwise, translation reactions were incubated for 4 min with 0.06 pmol of each RNA substrate, and terminated by incubation for 3 min with 2 mM cycloheximide or GMP-PNP. Where indicated, translation initiation was subjected to competitive inhibition by 2.7 mM cap analogue (m 7 GpppG), a concentration that readily distinguishes between initiation complexes that are, respectively, sensitive or resistant to this compound. Toeprinting used two different primers that were complementary to their respective targets at comparable distances from the AUG of interest. Primer no. 3029 was used for mRNAs spanning 600 nt (miniUAA2) to 2,135 nt (AAA), and primer no. 55 was used with miniUAA1 mRNA. Samples from translation reactions programmed with ADE2 and miniADE2 mRNAs were toeprinted with primer no. 172, complementary to the sequence 59-CACTAAAGAATCTTCAA-GTAAAACATCCC-39, and primer no. 3238, complementary to the sequence 59-GGACTTCATACATAGAAATCAACG-39, respectively. For mRNA-ribosome association assays, the equivalent of four translation reactions were fractionated in an 11-ml sucrose gradient (7-47%). The gradients were fractionated and scanned at 254 nm, and the resulting absorbance profiles were used to determine the position of the polysomal and non-polysomal fractions 30 . RNA was extracted from each fraction and analysed by northern blotting as described previously 30 .
